Adi Barzel
Impact in
- Genetics top 5%
- Virus-based gene therapy research
Papers in
- Co-authors
- Martin Kupiec (4 shared papers)Mark A. Kay (7 shared papers)Miriam Horovitz‐Fried (3 shared papers)Alessio David Nahmad (4 shared papers)Matthew Hebden Porteus (1 shared paper)Yun Bo Shi (1 shared paper)Yuanhua HUANG (1 shared paper)K. Chu (1 shared paper)
- Journals
- Frontiers in Immunology (3 papers)JCI Insight (2 papers)Nature Biotechnology (2 papers)Nature Reviews Genetics (1 paper)Molecular Therapy (1 paper)
- Partner nations
- IsraelUnited StatesItaly
In The Last Decade
Adi Barzel
21 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 70
- Genetics 445
- Business and International Management 25
- Molecular Biology 797
- Oncology 213
- Clinical Biochemistry 42
Countries citing papers authored by Adi Barzel
This map shows the geographic impact of Adi Barzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adi Barzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adi Barzel more than expected).
Fields of papers citing papers by Adi Barzel
This network shows the impact of papers produced by Adi Barzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adi Barzel. The network helps show where Adi Barzel may publish in the future.
Co-authors
The 25 scholars most cited alongside Adi Barzel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 224 | |
| 2 | 2022 | 155 | |
| 3 | 2007 | 154 | |
| 4 | 2022 | 67 | |
| 5 | 2017 | 64 | |
| 6 | 2020 | 63 | |
| 7 | 2017 | 55 | |
| 8 | 2019 | 50 | |
| 9 | 2020 | 46 | |
| 10 | 2016 | 42 | |
| 11 | 2011 | 31 | |
| 12 | 2022 | 28 | |
| 13 | 2011 | 22 | |
| 14 | 2011 | 20 | |
| 15 | 2022 | 19 | |
| 16 | 2021 | 18 | |
| 17 | 2011 | 18 | |
| 18 | 2025 | 7 | |
| 19 | 2023 | 2 | |
| 20 | 2025 | 2 |
About Adi Barzel
Adi Barzel is a scholar working on Oncology, Genetics, Immunology, Molecular Biology and Virology, having authored 21 papers that have together received 1.1k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (8 papers), CAR-T cell therapy research (8 papers), Virus-based gene therapy research (7 papers), Immunotherapy and Immune Responses (4 papers), RNA and protein synthesis mechanisms (3 papers), RNA Interference and Gene Delivery (3 papers), T-cell and B-cell Immunology (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Genetics (445 citations), Business and International Management (25 citations), Molecular Biology (797 citations), Oncology (213 citations) and Clinical Biochemistry (42 citations). Adi Barzel has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Martin Kupiec, Mark A. Kay, Miriam Horovitz‐Fried, Alessio David Nahmad, Matthew Hebden Porteus, Yun Bo Shi, Yuanhua HUANG, K. Chu, Laura P. Spector and Nicole K. Paulk. Their work appears in journals such as Frontiers in Immunology, JCI Insight, Nature Biotechnology, Nature Reviews Genetics and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.